Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of neural transmission

• Publication date

  2018-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00702-017-1832-6PMID 29279995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disorders

  2019cited by this paper
• Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress☆

  2017cited by this paper
• Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression

  2017cited by this paper
• Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis

  2017cited by this paper
• Anti‐inflammatory and protective effects of MT‐031, a novel multitarget MAO‐A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells

  2017cited by this paper
• Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline

  2017cited by this paper
• Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels

  2017cited by this paper
• BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson׳s disease.

  2016cited by this paper
• MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy

  2016cited by this paper
• Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury.

  2016cited by this paper
• Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology

  2016cited by this paper
• Platelet monoamine oxidase type B, MAOB intron 13 and MAOA-uVNTR polymorphism and symptoms of post-traumatic stress disorder

  2016cited by this paper
• The role of monoamine oxidase A in aggression: Current translational developments and future challenges.

  2016cited by this paper
• Dissecting bipolar disorder complexity through epigenomic approach

  2016cited by this paper
• Monoamine oxidase and agitation in psychiatric patients.

  2016cited by this paper
• Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression

  2016cited by this paper
• Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets

  2016influential reference
• Hypomethylation of MAOA's first exon region in depression: a replication study.

  2015cited by this paper
• Evidence Revealing Deregulation of The KLF11-Mao A Pathway in Association with Chronic Stress and Depressive Disorders

  2015cited by this paper
• Beneficial behavioral, neurochemical and molecular effects of 1-(R)-aminoindan in aged mice.

  2015cited by this paper
• Specific binding of [18F]fluoroethyl‐harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain

  2015cited by this paper
• Monoamine oxidase a gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder

  2015cited by this paper
• Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection

  2015cited by this paper
• Relationship of Monoamine Oxidase-A Distribution Volume to Postpartum Depression and Postpartum Crying

  2015cited by this paper
• Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases.

  2014cited by this paper
• Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice

  2014cited by this paper
• Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity

  2014cited by this paper
• Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.

  2014cited by this paper
• Association of gene polymorphisms encoding dopaminergic system components and platelet MAO-B activity with alcohol dependence and alcohol dependence-related phenotypes.

  2014cited by this paper
• Hydrogen peroxide sensing, signaling and regulation of transcription factors

  2014cited by this paper
• H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.

  2014cited by this paper
• Role of Metabolic H2O2 Generation

  2014cited by this paper
• Monoamine oxidase‐A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins

  2014cited by this paper
• MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction.

  2014cited by this paper
• Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain

  2014cited by this paper
• ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning

  2014cited by this paper
• The expression of KLF11 (TIEG2), a monoamine oxidase B transcriptional activator in the prefrontal cortex of human alcohol dependence.

  2014cited by this paper
• Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms

  2013influential reference
• Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson’s Disease

  2013cited by this paper
• Radiochemistry devoted to the production of monoamine oxidase (MAO-A and MAO-B) ligands for brain imaging with positron emission tomography.

  2013cited by this paper
• Rines E3 Ubiquitin Ligase Regulates MAO-A Levels and Emotional Responses

  2013cited by this paper
• MicroRNA-142 Reduces Monoamine Oxidase A Expression and Activity in Neuronal Cells by Downregulating SIRT1

  2013cited by this paper
• Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells

  2013influential reference
• Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression*

  2012cited by this paper
• Monoamine Oxidase-A Physically Interacts with Presenilin-1(M146V) in the Mouse Cortex

  2012cited by this paper
• ‘‘70th Birthday Professor Riederer’’ Induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (−)deprenyl: a way to a disease-modifying therapy?

  2012influential reference
• Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men

  2012cited by this paper
• Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients.

  2012cited by this paper
• Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation.

  2012cited by this paper
• Herbal natural products as a source of monoamine oxidase inhibitors: a review.

  2012cited by this paper
• G/A polymorphism in intronic sequence affects the processing of MAO‐B gene in patients with Parkinson disease

  2012cited by this paper
• Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?

  2012cited by this paper
• Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).

  2012cited by this paper
• I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

  2012cited by this paper
• Convergent Effects of Acute Stress and Glucocorticoid Exposure upon MAO-A in Humans

  2012cited by this paper
• Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function?

  2012cited by this paper
• Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase

  2012cited by this paper
• Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.

  2012cited by this paper
• Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation

  2012cited by this paper
• Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study

  2011cited by this paper
• Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected].

  2011cited by this paper
• MAOA, abuse exposure and antisocial behaviour: 30-year longitudinal study

  2011cited by this paper
• Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases.

  2011cited by this paper
• Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

  2011cited by this paper
• Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro

  2011cited by this paper
• Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia

  2011cited by this paper
• SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive.

  2011cited by this paper
• Glia: Initiators and progressors of pathology in Parkinson's disease

  2011cited by this paper
• Monoamine Oxidase A Expression Is Vital for Embryonic Brain Development by Modulating Developmental Apoptosis*

  2011cited by this paper
• MAO-inhibitors in Parkinson's Disease

  2011cited by this paper
• The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder

  2011cited by this paper
• Annual Research Review: Epigenetic mechanisms and environmental shaping of the brain during sensitive periods of development.

  2011cited by this paper
• Transcriptional regulation and multiple functions of MAO genes

  2011cited by this paper
• Transcription Factor E2F-Associated Phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and Simian Virus 40 Promoter Factor 1 (Sp1) Cooperatively Regulate Glucocorticoid Activation of Monoamine Oxidase B

  2011cited by this paper
• Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by Anti-Parkinsonian Drug Therapy In Vivo

  2010cited by this paper
• Regulatory role of monoamine neurotransmitters in astrocytic NT‐3 synthesis

  2010cited by this paper
• Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity.

  2010cited by this paper
• Neuroglia in neurodegeneration.

  2010cited by this paper
• SIRT1 Is Essential for Normal Cognitive Function and Synaptic Plasticity

  2010cited by this paper
• Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons.

  2010cited by this paper
• Elevated brain monoamine oxidase A binding in the early postpartum period.

  2010cited by this paper
• Dopamine Induces Ca2+ Signaling in Astrocytes through Reactive Oxygen Species Generated by Monoamine Oxidase

  2010cited by this paper
• The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.

  2010cited by this paper
• Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone

  2009cited by this paper
• Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase‐A activity

  2009cited by this paper
• Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation

  2009cited by this paper
• Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans

  2009cited by this paper
• Retinoic Acid Activates Monoamine Oxidase B Promoter in Human Neuronal Cells*

  2009cited by this paper
• MAOA methylation is associated with nicotine and alcohol dependence in women

  2008cited by this paper
• Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia.

  2008cited by this paper
• MAOA and the neurogenetic architecture of human aggression.

  2008cited by this paper
• A Non-Additive Interaction of a Functional MAO-A VNTR and Testosterone Predicts Antisocial Behavior

  2008cited by this paper
• Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha1- and beta1/beta2-adrenergic receptors.

  2008cited by this paper
• Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women

  2008cited by this paper
• Serotonin (5‐HT) induces glial cell line‐derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells

  2008cited by this paper
• Association of A/G Polymorphism in Intron 13 of the Monoamine Oxidase B Gene with Schizophrenia in a Spanish Population

  2008cited by this paper
• Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study

  2008cited by this paper
• The Neuroprotective Effect of Antidepressant Drug via Inhibition of TIEG2-MAO B Mediated Cell Death.

  2008cited by this paper
• Reversal of hypermethylation and reactivation of genes by dietary polyphenolic compounds.

  2008cited by this paper
• Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production.

  2008cited by this paper

• Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism

  2025cites this paper
• Computational screening and identification of functional deleterious nsSNPs in the Human MAOB Gene

  2025cites this paper
• A New Insight in Cellular and Molecular Signaling Regulation for Neural Differentiation Program

  2025cites this paper
• Antioxidant compounds of leaves and seeds extracts of Parkia Speciosa overcome ferroptosis

  2025cites this paper
• Aging-Associated Amyloid-β Plaques and Neuroinflammation in Bottlenose Dolphins (Tursiops truncatus) and Novel Cognitive Health-Supporting Roles of Pentadecanoic Acid (C15:0)

  2025cites this paper
• In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis

  2024cites this paper
• Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration

  2024cites this paper
• Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease

  2024cites this paper
• Do boys with MAOA_LPR*2R allele present cognitive and learning impairments?

  2022cites this paper
• Effect of selegiline as a monomine oxidase B inhibitor on the expression of neurotrophin mRNA levels in a contusion rat model of spinal cord injury

  2022cites this paper
• Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies

  2022cites this paper
• Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.

  2022cites this paper
• DNA methylation signature as a biomarker of major neuropsychiatric disorders.

  2021cites this paper
• Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease

  2021influential citation
• Questions in the Chemical Enzymology of MAO

  2021cites this paper
• Early Life Stress Induced DNA Methylation of Monoamine Oxidases Leads to Depressive-Like Behavior

  2020cites this paper
• Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease

  2020cites this paper
• Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration.

  2020cites this paper
• Synthesis, biological evaluation, and molecular modeling of nitrile‐containing compounds: Exploring multiple activities as anti‐Alzheimer agents

  2020cites this paper
• Mitochondrial-targeted and Near-infrared Fluorescent Probe for Bioimaging and Evaluating Monoamine Oxidase A Activity in Hepatic Fibrosis.

  2020cites this paper
• Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review.

  2019cites this paper
• An investigation of plant derived compounds as inhibitors of monoamine oxidase

  2019cites this paper
• Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.

  2019cites this paper
• Neuroprotection of multifunctional phytochemicals as novel therapeutic strategy for neurodegenerative disorders: antiapoptotic and antiamyloidogenic activities by modulation of cellular signal pathways

  2019cites this paper
• A Novel Biomarker Renalase and Its Relationship with its Substrates in Schizophrenia

  2019cites this paper
• A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid

  2019cites this paper
• Therapeutic Advances in Neurological Disorders

  2018cites this paper
• Gene–environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions

  2018cites this paper